An oncology nurse raised concerns via a producer note regarding the long-term cancer risks associated with high-dose hormone replacement therapy (HRT). While HRT has been linked to non-genetic cancers in menopausal women, the note suggests that the "unprecedented" quantities used for gender transition could lead to a future epidemic of terminal cancers. There is currently a lack of long-term studies on the safety of these specific medical protocols.




